title: Response to the comparison of generic zidovudine plus lamivudine (Cipla, Duovir) and the GlaxoSmithKline brand (Combivir) tablets.
authors.forename: Vishal S
authors.initials: VS
authors.lastname: Narang
authors.forename: Anita
authors.initials: A
authors.lastname: Desai
authors.forename: Shrinivas
authors.initials: S
authors.lastname: Purandare
mesh_terms: D002851:Chromatography, High Pressure Liquid; D004338:Drug Combinations; D016568:Drugs, Generic / Q000032:analysis* / Q000191:economics; D015658:HIV Infections / Q000188:drug therapy / Q000191:economics; D006801:Humans; D019259:Lamivudine / Q000032:analysis*; D013607:Tablets / Q000032:analysis* / Q000592:standards; D015215:Zidovudine / Q000032:analysis* / Q000191:economics / Q000592:standards
chemical_list: D004338:Drug Combinations; D016568:Drugs, Generic; D013607:Tablets; D019259:Lamivudine; D015215:Zidovudine